Showing results (961-970 of 1,209) with videos related to

Sort By:
Pageof 121
Plos Medicine|September 17, 2014
Genetic predisposition to increased blood cholesterol and triglyceride lipid levels and risk of Alzheimer disease: a Mendelian randomization analysisPetroula Proitsi, Michelle K Lupton, Latha Velayudhan, et al.
Psychological Medicine|September 8, 2012
Anxiety is related to Alzheimer cerebrospinal fluid markers in subjects with mild cognitive impairmentI H G B Ramakers, F R J Verhey, P Scheltens, et al.
Alzheimer'S Research & Therapy|June 6, 2019
Brain volumes and cortical thickness on MRI in the Finnish Geriatric Intervention Study to Prevent Cognitive Impairment and Disability (FINGER)Ruth Stephen, Yawu Liu, Tiia Ngandu, et al.
Genetic Epidemiology|January 1, 1994
Interaction between genetic and environmental risk factors for Alzheimer's disease: a reanalysis of case-control studiesC M Van Duijn, D G Clayton, V Chandra, et al.
Frontiers in Aging Neuroscience|February 2, 2019
Differential Associations of IL-4 With Hippocampal Subfields in Mild Cognitive Impairment and Alzheimer's DiseaseVirginia Boccardi, Eric Westman, Luca Pelini, et al.
Plos One|March 3, 2011
Deep sequencing of the Nicastrin gene in pooled DNA, the identification of genetic variants that affect risk of Alzheimer's diseaseMichelle K Lupton, Petroula Proitsi, Makrina Danillidou, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|June 23, 2009
White matter hyperintensities and medial temporal lobe atrophy in clinical subtypes of mild cognitive impairment: the DESCRIPA studyL A van de Pol, F Verhey, G B Frisoni, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|September 19, 2012
Targeted delivery via avidin fusion protein: intracellular fate of biotinylated doxorubicin derivative and cellular uptake kinetics and biodistribution of biotinylated liposomesSuvi K Soininen, Pauliina Lehtolainen-Dalkilic, Tanja Karppinen, et al.
Neurobiology of Aging|November 14, 2006
MRI of hippocampus and entorhinal cortex in mild cognitive impairment: a follow-up studyTero Tapiola, Corina Pennanen, Mia Tapiola, et al.
Alzheimer'S Research & Therapy|January 10, 2021
Metabolic phenotyping reveals a reduction in the bioavailability of serotonin and kynurenine pathway metabolites in both the urine and serum of individuals living with Alzheimer's diseaseLuke Whiley, Katie E Chappell, Ellie D'Hondt, et al.
Pageof 121